Post Categories
Solutions for Recruitment for Pediatric Clinical Trials
September 3, 2019
Did you know that only about 20 percent of drugs used today are labeled for pediatric patients? By necessity, products licensed for adults are…
Establishing Preclinical Leadership in Asia with the Addition of Mini Pig Studies
August 19, 2019
Suitable animal models are an unavoidable necessity in the testing and development of new pharmacological agents. QPS has an extensive history of conducting studies…
Establishing Leadership in Asia with SEND
August 12, 2019
As a pioneer with the Standard for Exchange Nonclinical Data (SEND) system in Asia, QPS Taiwan CTPS has taken a leadership role in implementing…
QPS Missouri Collaborates with Local Agency to Bring Birthday Celebrations to Underserved Children
August 8, 2019
Wish I May is a volunteer-run 501(c)(3) non-profit organization in the Springfield, Missouri, community striving to make a difference one child and one birthday at…
Interested in Plaque-Associated Inflammation?
July 19, 2019
Are you interested in exploring plaque-associated inflammation? QPS Neuropharmacology, a division of QPS (a leading CRO for drug development), is your partner for the visualization…
Available Now! Tiotropium Assay for Generic and 505(b)(2) Studies.
July 12, 2019
While the wave of small molecule drug therapies going off patent has peaked, there are still a number that will be losing patent protection…
Impact of Biomarkers on Current Parkinson’s Disease Treatment Research
July 8, 2019
About a century ago, Otto Loewi discovered in his laboratories in Graz, Austria, that nerve impulses are transmitted by chemical messengers like acetylcholine. Since…
The 6 C’s of Innovation in Customer Excellence
July 1, 2019
Although customer service is a critical component of the global economy, there is surprisingly little innovation in the field compared to the ingenuity in…
QPS Celebrating Sustained Growth in Asia
June 24, 2019
Did you know that 23.6 percent of the world’s pharmaceutical companies are now located in Asia? That’s up from 20.5 percent in 2018 –…
Conference Report: EAACI Annual Conference in Lisbon, Portugal on June 1 – 5, 2019
June 17, 2019
Professor Zuzana Diamant, MD PhD, Executive Medical and Scientific Director of Respiratory & Allergy at QPS Netherlands, and EAACI Asthma Section Chair 2017-2019, lectured…
Power Women in Business Development at QPS Netherlands
June 13, 2019
Two power women currently ‘man’ the Business Development (BD) department at QPS Netherlands, in close collaboration with the Head of BD, Edwin van Vulpen,…
Inflammatory Disease Models and Biomarkers
June 10, 2019
Trained and supervised by internationally recognized experts, we have acquired skills in a variety of inflammatory disease models at QPS. Such models can be…
The Gut-Brain Connection in Alzheimer’s Disease
March 27, 2023
Neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease, are often associated with the build-up of cellular debris, like misfolded proteins, within the…
Can We Reverse Aging by Targeting Old Cells?
March 22, 2023
James Kirkland and Tamara Tchkonia, researchers at the Mayo Clinic, are at the forefront of a movement focused on stopping chronic disease by targeting…
Harnessing the Power of Monoclonal Antibodies in the Fight Against Malaria
March 20, 2023
Monoclonal antibodies have been deployed to treat a variety of diseases, from cancer to COVID-19. Now this treatment approach, which doesn’t depend on the…
First Vaccine for Honeybees Prevents American Foulbrood
March 15, 2023
A healthy honeybee population is a critical component of healthy ecosystems, clean air, and stable soil. Honeybees also play a critical role in food…
Precision Steering of CAR-T Therapies May Effectively Target More Tumor Types
March 13, 2023
Recent years have seen increased research interest in the potential of chimeric antigen receptor (CAR)-T cancer therapies. This approach uses genetic engineering to modify…
First Malaria Vaccine Is a Milestone Achievement and Poses a Manufacturing Challenge
March 6, 2023
Following 30 years of research and development, the first malaria vaccine was recommended by the World Health Organization (WHO) for widespread use in children…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…